Abstract:Replication of the complex retrovirus mouse mammary tumor virus (MMTV) is antagonized by murine Apobec3 (mA3), a member of the Apobec family of cytidine deaminases. We have shown that MMTV-encoded Rem protein inhibits proviral mutagenesis by the Apobec enzyme, activation-induced cytidine deaminase (AID) during viral replication in BALB/c mice. To further study the role of Rem in vivo , we have infected C57BL/6 (B6) mice with a superantigen-independent lymphomagenic strain of MMTV (TBLV-WT) or a mutant strain that is defective in Rem and its cleavage product Rem-CT (TBLV-SD). Compared to BALB/c, B6 mice were more susceptible to TBLV infection and tumorigenesis. Furthermore, unlike MMTV, TBLV induced T-cell tumors in B6 μMT mice, which lack membrane-bound IgM and conventional B-2 cells. At limiting viral doses, loss of Rem expression in TBLV-SD-infected B6 mice accelerated tumorigenesis compared to TBLV-WT in either wild-type B6 or AID-knockout mice. Unlike BALB/c results, high-throughput sequencing indicated that proviral G-to-A or C-to-T mutations were unchanged regardless of Rem expression in B6 tumors. However, knockout of both AID and mA3 reduced G-to-A mutations. Ex vivo stimulation showed higher levels of mA3 relative to AID in B6 compared to BALB/c splenocytes, and effects of agonists differed in the two strains. RNA-Seq revealed increased transcripts related to growth factor and cytokine signaling in TBLV-SD-induced tumors relative to TBLV-WT-induced tumors, consistent with another Rem function. Thus, Rem-mediated effects on tumorigenesis in B6 mice are independent of Apobec-mediated proviral hypermutation. Retroviruses cause lifelong infections resulting from their ability to thwart innate immunity. The Apobec family of cytidine deaminases are part of the innate immune response that recognizes and mutates foreign nucleic acids, including those from multiple viruses. Retroviral antagonists of Apobecs have been identified, including mouse mammary tumor virus (MMTV)-encoded Rem protein. Previous experiments have shown that Rem-null MMTV or closely related TBLV proviruses from BALB/c tumors accumulate G-to-A and C-to-T mutations typical of Apobecs compared to wild-type proviruses expressing Rem. The difference in mutations between Rem-expressing and non-expressing MMTV strains largely disappeared in mice lacking the Apobec family member, activation-induced cytidine deaminase (AID). These results suggested that Rem is an AID antagonist. In this study, we attempted to study AID-mediated mutations of TBLV proviruses lacking Rem expression obtained from tumors in C57BL/6 (B6) wild-type and AID-knockout backgrounds. Surprisingly, no differences in G-to-A mutations were observed in TBLV proviruses regardless of Rem expression, yet such mutations were significantly reduced in proviruses obtained from mA3/AID-double knockout mice relative to those from wild-type B6 or AID-knockout mice. Many cellular mRNAs involving the innate immune response, but not Apobecs, were elevated in the absence relative to the presence of Rem expression on the B6 AID-knockout background. These results revealed that Apobec-mediated mutagenesis is dependent on mouse strain and suggested a second means of Rem-dependent immune evasion.

Retrovirus-induced Insertional Mutagenesis: Mechanism of Collagen Mutation in Mov13 Mice.

Rescue of type I collagen-deficient phenotype by retroviral-vector-mediated transfer of human pro alpha 1(I) collagen gene into Mov-13 cells

Human-Mouse Interspecies Collagen-I Heterotrimer is Functional During Embryonic-Development of Mov13 Mutant Mouse Embryos

Generation of Collagenase-Resistant Collagen by Site-Directed Mutagenesis of Murine Pro Alpha 1(I) Collagen Gene.

Type I Collagen-Deficient Mov-13 Mice Do Not Retain SPARC in the Extracellular Matrix: Implications for Fibroblast Function

Fibronectin binding site in type I collagen regulates fibronectin fibril formation.

A Targeted Mutation at the Known Collagenase Cleavage Site in Mouse Type-I Collagen Impairs Tissue Remodeling

Double Replacement: Strategy for Efficient Introduction of Subtle Mutations into the Murine Col1a-1 Gene by Homologous Recombination in Embryonic Stem Cells.

The Mouse MC13 Mutant Is a Novel ENU Mutation in Collagen Type II, Alpha 1

Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death

The MOV10 RNA helicase is a dosage-dependent host restriction factor for LINE1 retrotransposition in mice

An X-linked Human Collagen Transgene Escapes X Inactivation in a Subset of Cells.

Collagenase-resistant collagen promotes mouse aging and vascular cell senescence.

Deletion of Col15a1 Modulates the Tumour Extracellular Matrix and Leads to Increased Tumour Growth in the MMTV-PyMT Mouse Mammary Carcinoma Model

Postnatal Expression in Hyaline Cartilage of Constitutively Active Human Collagenase-3 (Mmp-13) Induces Osteoarthritis in Mice

Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta

A humanized knock-in mouse recapitulates a deep-intronic splice-activating variant

Myristylation-dependent transactivation by FBR v-fos is regulated by C/EBP

Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain

Identification of a cell-specific transcriptional enhancer in the first intron of the mouse alpha 2 (type I) collagen gene.

Different Collagenase Gene Products Have Different Roles in Degradation of Type I Collagen